There is increasing evidence that digital intervention, or “digital therapeutics,” can provide equal or better health outcomes as chemical therapeutics, especially in the area of lifestyle-related chronic illnesses. Given the promise of these new digital healthcare offerings, there is a growing need for a better strategy to get digital therapeutics into the mainstream.
In a recent article, Dr. Joseph Kvedar of Partners Connected Health outlines a strategy that includes all of the parties in healthcare: developers, providers, regulators, payers and consumers.
